CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Study BWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug797 Study C Wiki 1.00
drug795 Study A Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.06

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City

This study is to gain critical knowledge to understand the factors influencing the outcome of a pandemic virus within the city of Basel.

NCT04351503 SARS Coronavirus (SARS-CoV-2) Infection Other: Study A Other: Study B Other: Study C
MeSH:Coronavirus Infections

Primary Outcomes

Description: Identification of factors associated with (i) infection (binary, yes/no), (ii) hospitalization (binary, yes/no), (iii) requirement for ICU treatment (binary, yes/no)

Measure: Identification of factors associated with (i) infection (binary, yes/no), (ii) hospitalization (binary, yes/no), (iii) requirement for ICU treatment (binary, yes/no)

Time: at baseline

Description: duration of hospitalization (in days)

Measure: duration of hospitalization (in days)

Time: at baseline

Description: duration of ICU stay (in days)

Measure: duration of Intensive Care Unit (ICU) stay (in days)

Time: at baseline

Description: in-hospital mortality (binary, yes/no)

Measure: in-hospital mortality (binary, yes/no)

Time: at baseline

Description: Number of infected cases confirmed either by nucleic acid test (NAT) or by positive serology within the city of Basel expressed as incidence per statistical block

Measure: Number of infected cases within the city of Basel

Time: at baseline

Description: Number, type, and complexity of viral genome variants and quasispecies identified by deep-sequencing during rise, peak, and contraction of the pandemic in patients and geographic areas.

Measure: whole genome sequencing to study pathogen evolution (number, type, and complexity of viral genome)

Time: at baseline


No related HPO nodes (Using clinical trials)